2015 American Transplant Congress » Concurrent Session: Liver Transplantation: Viral Hepatitis

Date: Monday, May 4, 2015

Time: 2:15pm-3:45pm

Location: Terrace IV

Session Type: Concurrent Session

Meeting: 2015 American Transplant Congress

2:15pm-2:27pm: Significant Association Between Foxp3 Gene Polymorphism and Outcomes in HBV-Related Liver Transplant Patients

Y. Tanaka, V. Sapana, H. Ohdan.

2:27pm-2:39pm: Safety and Efficacy of All Oral DAA Therapy for Genotype 1 HCV Post-Liver Transplant: Interval Results from the HCV-TARGET Multicenter Prospective Observational Study

J. O'Leary,¹ R. Brown,² K. Reddy,³ A. Kuo,⁴ G. Morelli,⁵ R. Stravitz,⁶ G. Everson,⁷ C. Durand,⁸ H. Vargas,⁹ P. Kwo,¹⁰ C. Frenette,¹¹ J. Peter,¹² M. Vainorius,¹² L. Akushevich,¹² D. Nelson,⁵ M. Fried,¹² N. Terrault.¹³

2:39pm-2:51pm: Changes in Utilization, Discard, and Outcomes Associated With Hepatitis C (+) Donor Livers in the Era of Direct Acting Anti-Retroviral Therapy

M. Bowring, L. Kucirka, X. Luo, A. Massie, D. Segev, C. Durand.

2:51pm-3:03pm: The Impact of the New Antivirals Sofosfuvir/Ledipasvir on Liver Transplantation for Hepatitis C Cirrhosis

S. Munoz,¹ D. Reich,² K. Rothstein.¹

3:03pm-3:15pm: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Co-Infected Recipients: The “Real World” Experience

D. Sawinski,¹ G. David,² E. Blumberg,³ P. Abt,⁴ R. Bloom,¹ K. Forde.²

3:15pm-3:27pm: Post-Liver Transplant Metabolic Syndrome Increases the Risk of Recurrent Fibrosis in Patients With Hepatitis C

R. Sharma, M. Laurito, R. Brown, Jr., E. Verna.

3:27pm-3:39pm: Validation of the Model for End-Stage Liver Disease Score Criteria in Liver Transplantation for Acute Flare Up of Hepatitis B in Non-Cirrhotic Liver

W.-C. Lee,¹ T.-J. Wu,¹ C.-F. Lee,¹ R.-S. Soong,¹ C.-H. Cheng,¹ H.-S. Chou,¹ T.-H. Wu,¹ K.-M. Chan,¹ Y.-C. Wang,¹ C.-S. Lee.²

« View all sessions from the 2015 American Transplant Congress